This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Nov;10(11):2013-4.

doi: 10.1158/1535-7163.MCT-11-0716.

First report of functional Chk1 siRNA studies applied to drug discovery

Zehan Chen¹

Affiliations

PMID: 22072800
DOI: 10.1158/1535-7163.MCT-11-0716

Comment

First report of functional Chk1 siRNA studies applied to drug discovery

Zehan Chen. Mol Cancer Ther. 2011 Nov.

. 2011 Nov;10(11):2013-4.

doi: 10.1158/1535-7163.MCT-11-0716.

Author

Zehan Chen¹

Affiliation

¹ Zehan Chen, Cancer Research, Abbott Laboratories, Abbott Park, IL 60064, USA. zehan.chen@abbott.com

PMID: 22072800
DOI: 10.1158/1535-7163.MCT-11-0716

No abstract available

PubMed Disclaimer

Comment on

Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint.
Chen Z, Xiao Z, Chen J, Ng SC, Sowin T, Sham H, Rosenberg S, Fesik S, Zhang H. Chen Z, et al. Mol Cancer Ther. 2003 Jun;2(6):543-8. Mol Cancer Ther. 2003. PMID: 12813133

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Miscellaneous
- NCI CPTAC Assay Portal